Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis
ICD-10 N04.4 is a billable code used to indicate a diagnosis of nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis.
Nephrotic syndrome is characterized by a triad of symptoms: significant proteinuria, hypoalbuminemia, and edema. When associated with diffuse endocapillary proliferative glomerulonephritis, it indicates an inflammatory process affecting the glomeruli, leading to increased permeability and resultant protein loss in urine. Patients typically present with symptoms such as swelling, particularly in the legs and around the eyes, and may also experience hematuria (blood in urine). Renal biopsy findings often reveal diffuse hypercellularity, glomerular capillary loop thickening, and immune complex deposition. Management in nephrology includes corticosteroids, immunosuppressants, and supportive care to control symptoms and prevent complications such as infections and thromboembolic events. Regular monitoring of renal function and proteinuria is essential to assess treatment efficacy and disease progression.
Detailed clinical notes on symptoms, lab results, and treatment plans.
Patients presenting with edema, proteinuria, and renal impairment.
Ensure renal biopsy results are clearly documented to support diagnosis.
Comprehensive reports on renal biopsy findings.
Evaluation of renal tissue for glomerular diseases.
Pathology reports should correlate with clinical findings for accurate coding.
Used when a renal biopsy is performed to confirm diagnosis.
Biopsy report must be included in the patient's medical record.
Nephrologists should ensure that the biopsy findings correlate with clinical symptoms.
Key symptoms include significant proteinuria, edema, and hypoalbuminemia. Patients may also experience hematuria and fatigue.
Diagnosis is typically made through renal biopsy, which reveals hypercellularity and immune complex deposition in the glomeruli.
